EGFR and pancreatic neoplasm: KEGG analysis of predicted target genes from differentially expressed miRNAs in HTLV-1 and HTLV-2 asymptomatic carriers revealed significant enrichment in cancer-related pathways, signaling cascades (e.g., FoxO, Ras, MAPK), and viral infection processes, with pancreatic cancer, pathways in cancer, and EGFR tyrosine kinase inhibitor resistance as the top three enriched pathways as shown in Figure 9.